GlassScriptPhysician profile
David A Papermaster
NPI 1225023708
$3,378.06
in general payments reported to CMS, 2019-2025
36 companies · $772 in 2025
The $772 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $838 · 2022: $860 · 2023: $629 · 2024: $278 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Education: $422 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.28 |
| Education | $421.98 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,242.67 | 2021-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $257.58 | 2025 | |
| Janssen Biotech, INC. | $163.20 | 2021-2025 | Erleada |
| Halozyme INC | $141.38 | 2023 | |
| Merck Sharp & Dohme LLC | $140.30 | 2023-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Amgen INC. | $139.51 | 2021-2022 | |
| Urogen Pharma, INC. | $110.15 | 2021-2023 | Jelmyto |
| Abbvie INC. | $107.75 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.06 | 2021 | |
| Antares Pharma, INC. | $88.53 | 2021-2025 | Xyosted |
| 180 Medical, INC. | $82.92 | 2022-2025 | Gentlecath, Gentlecath Glide |
| Myovant Sciences INC. | $80.70 | 2021-2022 | |
| Coloplast Corp | $70.87 | 2021-2025 | Speedicath |
| Rochester Medical Corporation | $65.42 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $62.10 | 2021-2024 | Lynparza |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $60.98 | 2024-2025 | Orgovyx |
| Clarus Therapeutics INC. | $44.82 | 2021 | |
| Olympus America INC. | $43.25 | 2025 | Itind System |
| Endo Pharmaceuticals INC. | $38.13 | 2021-2023 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $31.83 | 2021-2022 | |
| Boston Scientific Corporation | $30.74 | 2025 | Axonics |
| Foundation Medicine, INC. | $25.45 | 2021 | |
| Becton, Dickinson and Company | $24.00 | 2025 | Purewick Female External Catheter |
| Urovant Sciences INC | $23.46 | 2022 | |
| Ferring Pharmaceuticals INC. | $23.17 | 2024 | Adstiladrin |
| Convatec INC. | $19.43 | 2021 | |
| Tolmar, INC. | $19.08 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $18.77 | 2021 | |
| Allergan, INC. | $17.29 | 2021 | |
| Pfizer INC. | $16.80 | 2024 | |
| Endo USA, INC. | $16.58 | 2024 | Xiaflex, Aveed |
| Profound Medical Corp. | $15.55 | 2025 | Tulsa-Pro |
| Telix Pharmaceuticals | $15.30 | 2023 | Illuccix |
| Mission Pharmacal Company | $14.65 | 2022 | |
| Teleflex LLC | $12.35 | 2022 | |
| Axonics, INC. | $11.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Papermaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.